---
title: "MediciNova CEO Iwaki base salary rises to $690,246 under new employment agreement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296348115.md"
description: "MediciNova signed new executive employment agreements on Aug. 17, 2026, for CEO Yuichi Iwaki and CMO Kazuko Matsuda. Iwaki's base salary is set at $690,246 with a 55% target bonus, while Matsuda's is $540,143 with a 40% target bonus. Severance terms include 12 months' pay for involuntary termination without change of control, and 24 months (Iwaki) or 18 months (Matsuda) with full equity vesting for change-in-control terminations."
datetime: "2026-08-19T11:31:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296348115.md)
  - [en](https://longbridge.com/en/news/296348115.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296348115.md)
generator: "portal-rs"
---

# MediciNova CEO Iwaki base salary rises to $690,246 under new employment agreement

-   MediciNova signed new executive employment agreements on Aug. 17, 2026 for CEO Yuichi Iwaki, CMO Kazuko Matsuda. \* Iwaki base salary set at USD 690,246; target annual bonus set at 55% of base salary. \* Matsuda base salary set at USD 540,143; target annual bonus set at 40% of base salary. \* Involuntary termination without a change in control triggers 12 months’ salary severance, up to 12 months of company-paid COBRA. \* Change-in-control involuntary termination triggers 24 months’ pay for Iwaki, 18 months for Matsuda, both with target bonus and full equity vesting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediciNova Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-356146), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [MNOV.US](https://longbridge.com/en/quote/MNOV.US.md)
- [4875.JP](https://longbridge.com/en/quote/4875.JP.md)

## Related News & Research

- [3 Promising Penny Stocks With Over $50M Market Cap](https://longbridge.com/en/news/296943644.md)
- [IBA publishes H1 2026 results presentation](https://longbridge.com/en/news/297180350.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)
- [Geox opens warrant exercise period at EUR 0.34 per share](https://longbridge.com/en/news/297074532.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**